ABT.SW

Abbott Laboratories [ABT.SW] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ABT.SW Stock Summary

In the News

ABT.SW Financial details

Company Rating
Strong Buy
Market Cap
175.63B
Income
5.8B
Revenue
41.51B
Book val./share
-
Cash/share
-
Dividend
1.96
Dividend %
1.76%
Employees
115K
Optionable
No
Shortable
Yes
Earnings
18 Jul 2023
P/E
33.44
Forward P/E
14.98
PEG
-37.25
P/S
4.68
P/B
5.29
P/C
-
P/FCF
24.88
Quick Ratio
1.23
Current Ratio
1.63
Debt / Equity
-
LT Debt / Equity
0.42
-
-
EPS (TTM)
3.65
EPS next Y
6.11
EPS next Q
-
EPS this Y
-0.75%
EPS next Y
67.36%
EPS next 5Y
67.36%
EPS last 5Y
24.16%
Revenue last 5Y
7.38%
Revenue Q/Q
-3.41%
EPS Q/Q
28.81%
-
-
-
-
SMA20
-
SMA50
-11.17%
SMA100
-9.41%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
16%
ROC
0.12%
Gross Margin
55%
Oper. Margin
17%
Profit Margin
14%
Payout
57%
Shs Outstand
1.74B
Shs Float
1.73B
-
-
-
-
Target Price
-
52W Range
98.0-121.0
52W High
-24.38%
52W Low
-6.63%
RSI
0.3
Rel Volume
-
Avg Volume
-
Volume
Perf Week
0%
Perf Month
0%
Perf Quarter
-9.41%
Perf Half Y
-9.41%
-
-
-
-
Beta
0.662913
-
-
Volatility
0%, 0%
Prev Close
0%
Price
91.5
Change
0%

ABT.SW Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
17.4218.119.5424.4225.04
Net income per share
1.352.092.544.013.98
Operating cash flow per share
3.593.484.465.975.5
Free cash flow per share
2.792.553.234.94.48
Cash per share
2.332.354.045.815.83
Book value per share
17.3917.6418.5120.2921.04
Tangible book value per share
-6.54-5.06-3.120.032.09
Share holders equity per share
17.3917.6418.5120.2921.04
Interest debt per share
11.6211.0511.3811.0510.38
Market cap
121.36B157.18B205.33B227.82B190.49B
Enterprise value
137.08B172.21B218.14B237.03B198.32B
P/E ratio
51.2542.6345.6832.2227.48
Price to sales ratio
3.974.935.935.294.36
POCF ratio
19.2625.6225.9921.6319.88
PFCF ratio
24.7434.9435.8726.3424.41
P/B Ratio
3.985.066.266.365.19
PTB ratio
3.985.066.266.365.19
EV to sales
4.485.46.35.54.54
Enterprise value over EBITDA
19.5525.8628.7322.0518.54
EV to operating cash flow
21.7628.0727.6122.520.7
EV to free cash flow
27.9438.2938.1127.4125.41
Earnings yield
0.020.020.020.030.04
Free cash flow yield
0.040.030.030.040.04
Debt to equity
1.191.181.211.091.02
Debt to assets
0.540.540.550.520.5
Net debt to EBITDA
2.242.261.690.860.73
Current ratio
1.621.441.721.851.63
Interest coverage
4.427.8710.7117.1922.3
Income quality
2.661.661.761.491.38
Dividend Yield
0.020.010.010.010.02
Payout ratio
0.830.620.570.450.48
Sales general and administrative to revenue
00000
Research and developement to revenue
0.080.080.070.060.07
Intangibles to total assets
0.630.590.530.480.45
Capex to operating cash flow
-0.22-0.27-0.28-0.18-0.19
Capex to revenue
-0.05-0.05-0.06-0.04-0.04
Capex to depreciation
-0.43-0.54-0.65-0.53-0.54
Stock based compensation to revenue
0.020.020.020.010.02
Graham number
22.9728.8132.5142.7843.39
ROIC
0.050.070.090.140.14
Return on tangible assets
0.090.130.130.180.17
Graham Net
-15.14-14.88-14.16-12.18-10.1
Working capital
5.62B4.8B8.53B11.13B9.74B
Tangible asset value
-11.47B-8.92B-5.53B54M3.65B
Net current asset value
-21.82B-20.92B-19.1B-14.93B-12.31B
Invested capital
0.640.610.60.530.48
Average receivables
5.22B5.3B5.92B6.45B7.68B
Average payables
2.69B3.11B3.6B4.18B4.51B
Average inventory
3.7B4.06B4.66B5.08B5.67B
Days sales outstanding
61.8662.0767.6554.9774.26
Days payables outstanding
85.4689.719686.887.85
Days of inventory on hand
109.05119.06121.93101.54117.71
Receivables turnover
5.95.885.46.644.92
Payables turnover
4.274.073.84.214.15
Inventory turnover
3.353.072.993.593.1
ROE
0.080.120.140.20.19
Capex per share
-0.79-0.93-1.23-1.07-1.02

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q1

Metric History 2022-03-312022-06-302022-09-302022-12-31 2023-03-31
Revenue per share
6.796.438.345.815.61
Net income per share
1.41.151.150.590.76
Operating cash flow per share
1.181.382.231.340
Free cash flow per share
11.161.850.990
Cash per share
4.665.37.945.850
Book value per share
20.2220.8428.5921.110
Tangible book value per share
0.131.362.22.10
Share holders equity per share
20.2220.8428.5921.110
Interest debt per share
9.839.6313.2210.230
Market cap
208.07B191.59B135.67B189.86B180.76B
Enterprise value
217.49B199.42B142.49B197.69B0
P/E ratio
21.2623.7423.6445.9534.29
Price to sales ratio
17.4917.0213.0318.8118.55
POCF ratio
100.7679.548.881.620
PFCF ratio
119.3194.3358.66110.640
P/B Ratio
5.885.253.85.180
PTB ratio
5.885.253.85.180
EV to sales
18.2817.7113.6919.590
Enterprise value over EBITDA
62.167.2660.35105.830
EV to operating cash flow
105.3282.7551.2684.990
EV to free cash flow
124.7198.1961.6115.20
Earnings yield
0.010.010.010.010.01
Free cash flow yield
0.010.010.020.010
Debt to equity
1.081.031.031.020
Debt to assets
0.520.510.510.50
Net debt to EBITDA
2.692.642.894.190
Current ratio
1.852.011.861.630
Interest coverage
24.8922.4220.5819.7629.02
Income quality
0.841.191.942.250
Dividend Yield
000.0100
Payout ratio
0.340.410.580.80
Sales general and administrative to revenue
00000
Research and developement to revenue
0.060.060.080.070.07
Intangibles to total assets
0.480.460.460.450
Capex to operating cash flow
-0.16-0.16-0.17-0.260
Capex to revenue
-0.03-0.03-0.04-0.060
Capex to depreciation
-0.39-0.46-0.57-0.760
Stock based compensation to revenue
0.030.010.010.010
Graham number
25.2123.2427.216.80
ROIC
0.050.040.030.020
Return on tangible assets
0.060.050.040.030
Graham Net
-12.56-11.33-15.5-10.140
Working capital
10.78B12.56B11.48B9.74B0
Tangible asset value
225M2.38B2.75B3.65B0
Net current asset value
-14.95B-12.53B-12.07B-12.31B0
Invested capital
0.480.460.460.480
Average receivables
6.83B7.19B6.8B7.64B0
Average payables
4.58B4.63B4.31B4.37B0
Average inventory
5.42B5.8B5.82B5.95B0
Days sales outstanding
54.3257.5655.479.210
Days payables outstanding
85.8581.9780.3690.270
Days of inventory on hand
102.71107.62111.48120.960
Receivables turnover
1.661.561.621.140
Payables turnover
1.051.11.1210
Inventory turnover
0.880.840.810.740
ROE
0.070.060.040.030
Capex per share
-0.18-0.22-0.37-0.350

ABT.SW Frequently Asked Questions

What is Abbott Laboratories stock symbol ?

Abbott Laboratories is a US stock , located in North chicago of Il and trading under the symbol ABT.SW

What is Abbott Laboratories stock quote today ?

Abbott Laboratories stock price is $91.5 today.

Is Abbott Laboratories stock public?

Yes, Abbott Laboratories is a publicly traded company.

Something similar

Top by Market Cap
Same Price Range